Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended
	Jun. 29, 2013	Jun. 30, 2012
Cash Flows From Operating Activities
Net income (loss)	$ 478,803	$ (8,425,810)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation of leasehold improvements and equipment	134,325	166,748
Amortization of intangibles	10,621	6,799
Share-based compensation expense	728,349	1,264,524
Gain on sale of assets	(2,891,917)
Loss from disposal of equipment		1,879
Interest added to note receivable	(31,824)
Changes in operating assets and liabilities:
Trade receivables	770,994	(264,536)
Inventories	(206,824)	(2,348,197)
Prepaid expenses and other assets	(51,010)	369,527
Accounts payable	(907,337)	1,151,141
Accrued expenses	(150,095)	(213,521)
Customer deposits and other	26,557	(30,081)
Deferred rent	3,298	(30,034)
Net cash used in operating activities	(2,086,060)	(8,351,561)
Cash Flows From Investing Activities
Purchases of leasehold improvements and equipment	(39,011)	(12,214)
Purchase of intangible assets	(40,000)	(2,000)
Proceeds from sale of assets	750,000
Net cash provided by (used in) investing activities	670,989	(14,214)
Cash Flows From Financing Activities
Proceeds from issuance of common stock, net of issuance costs		10,158,438
Proceeds from exercise of stock options	131,769
Proceeds from exercise of warrants	1,638,748	45,000
Principal payments on capital leases	(48,815)	(44,806)
Net cash provided by financing activities	1,721,702	10,158,632
Net increase in cash	306,631	1,792,857
Cash Beginning of Period	520,000	420,152
Cash Ending of Period	826,631	2,213,009
Supplemental Disclosures of Cash Flow Information
Cash payments for interest	15,852	15,827
Supplemental Schedule of Noncash Investing Activity
Capital lease obligation incurred for the purchase of equipment	171,851	50,786
Supplemental Schedule of Noncash Share-based Compensation
Stock awards issued for services prior to the period	14,560
Changes in stock and warrant awards issued for future services	206,697
Supplemental Schedule of Noncash Activities Related to Sale of BlueScience Consumer Product Line
Assets transferred	3,526,677
Liabilities transferred	368,873
Consideration received, net of $750,000 cash proceeds	$ 5,299,721